The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models
Mesenchymal stem cells (MSCs), discovered and isolated from the bone marrow in the 1960s and with self-renewal capacity and multilineage differentiation potential, have valuable immunomodulatory abilities. Acute kidney injury (AKI) refers to rapid renal failure, which exhibits as quickly progressive...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2020/1873921 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832566488814321664 |
|---|---|
| author | Tianbiao Zhou Chunling Liao Shujun Lin Wenshan Lin Hongzhen Zhong Shuangyi Huang |
| author_facet | Tianbiao Zhou Chunling Liao Shujun Lin Wenshan Lin Hongzhen Zhong Shuangyi Huang |
| author_sort | Tianbiao Zhou |
| collection | DOAJ |
| description | Mesenchymal stem cells (MSCs), discovered and isolated from the bone marrow in the 1960s and with self-renewal capacity and multilineage differentiation potential, have valuable immunomodulatory abilities. Acute kidney injury (AKI) refers to rapid renal failure, which exhibits as quickly progressive decreasing excretion in few hours or days. This study was performed to assess the efficacy of MSCs in the treatment of AKI induced by ischemia-reperfusion using a meta-analysis method. A literature search using corresponding terms was performed in the following databases: Embase, Cochrane Library, PubMed, and ISI Web of Science databases up to Dec 31, 2019. Data for outcomes were identified, and the efficacy of MSCs for AKI was assessed using Cochrane Review Manager Version 5.3. Nineteen studies were eligible and recruited for this meta-analysis. MSC treatment can reduce the Scr levels at 1 day, 2 days, 3 days, 5 days, and >7 days (1 day: WMD=−0.56, 95% CI: -0.78, -0.34, P<0.00001; 2 days: WMD=−0.58, 95% CI: -0.89, -0.28, P=0.0002; 3 days: WMD=−0.65, 95% CI: -0.84, -0.45, P<0.00001; 5 days: WMD=−0.35, 95% CI: -0.54, -0.16, P=0.0003; and >7 days: WMD=−0.22, 95% CI: -0.36, -0.08, P=0.002) and can reduce the levels of BUN at 1 day, 2 days, 3 days, and 5 days (1 day: WMD=−11.72, 95% CI: -18.80, -4.64, P=0.001; 2 days: WMD=−33.60, 95% CI: -40.15, -27.05, P<0.00001; 3 days: WMD=−21.14, 95% CI: -26.15, -16.14, P<0.00001; and 5 days: WMD=−8.88, 95% CI: -11.06, -6.69, P<0.00001), and it also can reduce the levels of proteinuria at 3 days and >7 days and alleviate the renal damage in animal models of AKI. In conclusion, MSCs might be a promising therapeutic agent for AKI induced by ischemia-reperfusion. |
| format | Article |
| id | doaj-art-7f0975b3ba8a4178af1375a41094cf85 |
| institution | Kabale University |
| issn | 1687-966X 1687-9678 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Stem Cells International |
| spelling | doaj-art-7f0975b3ba8a4178af1375a41094cf852025-02-03T01:04:00ZengWileyStem Cells International1687-966X1687-96782020-01-01202010.1155/2020/18739211873921The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal ModelsTianbiao Zhou0Chunling Liao1Shujun Lin2Wenshan Lin3Hongzhen Zhong4Shuangyi Huang5Department of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, ChinaDepartment of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, ChinaDepartment of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, ChinaDepartment of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, ChinaDepartment of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, ChinaDepartment of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, ChinaMesenchymal stem cells (MSCs), discovered and isolated from the bone marrow in the 1960s and with self-renewal capacity and multilineage differentiation potential, have valuable immunomodulatory abilities. Acute kidney injury (AKI) refers to rapid renal failure, which exhibits as quickly progressive decreasing excretion in few hours or days. This study was performed to assess the efficacy of MSCs in the treatment of AKI induced by ischemia-reperfusion using a meta-analysis method. A literature search using corresponding terms was performed in the following databases: Embase, Cochrane Library, PubMed, and ISI Web of Science databases up to Dec 31, 2019. Data for outcomes were identified, and the efficacy of MSCs for AKI was assessed using Cochrane Review Manager Version 5.3. Nineteen studies were eligible and recruited for this meta-analysis. MSC treatment can reduce the Scr levels at 1 day, 2 days, 3 days, 5 days, and >7 days (1 day: WMD=−0.56, 95% CI: -0.78, -0.34, P<0.00001; 2 days: WMD=−0.58, 95% CI: -0.89, -0.28, P=0.0002; 3 days: WMD=−0.65, 95% CI: -0.84, -0.45, P<0.00001; 5 days: WMD=−0.35, 95% CI: -0.54, -0.16, P=0.0003; and >7 days: WMD=−0.22, 95% CI: -0.36, -0.08, P=0.002) and can reduce the levels of BUN at 1 day, 2 days, 3 days, and 5 days (1 day: WMD=−11.72, 95% CI: -18.80, -4.64, P=0.001; 2 days: WMD=−33.60, 95% CI: -40.15, -27.05, P<0.00001; 3 days: WMD=−21.14, 95% CI: -26.15, -16.14, P<0.00001; and 5 days: WMD=−8.88, 95% CI: -11.06, -6.69, P<0.00001), and it also can reduce the levels of proteinuria at 3 days and >7 days and alleviate the renal damage in animal models of AKI. In conclusion, MSCs might be a promising therapeutic agent for AKI induced by ischemia-reperfusion.http://dx.doi.org/10.1155/2020/1873921 |
| spellingShingle | Tianbiao Zhou Chunling Liao Shujun Lin Wenshan Lin Hongzhen Zhong Shuangyi Huang The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models Stem Cells International |
| title | The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models |
| title_full | The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models |
| title_fullStr | The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models |
| title_full_unstemmed | The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models |
| title_short | The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models |
| title_sort | efficacy of mesenchymal stem cells in therapy of acute kidney injury induced by ischemia reperfusion in animal models |
| url | http://dx.doi.org/10.1155/2020/1873921 |
| work_keys_str_mv | AT tianbiaozhou theefficacyofmesenchymalstemcellsintherapyofacutekidneyinjuryinducedbyischemiareperfusioninanimalmodels AT chunlingliao theefficacyofmesenchymalstemcellsintherapyofacutekidneyinjuryinducedbyischemiareperfusioninanimalmodels AT shujunlin theefficacyofmesenchymalstemcellsintherapyofacutekidneyinjuryinducedbyischemiareperfusioninanimalmodels AT wenshanlin theefficacyofmesenchymalstemcellsintherapyofacutekidneyinjuryinducedbyischemiareperfusioninanimalmodels AT hongzhenzhong theefficacyofmesenchymalstemcellsintherapyofacutekidneyinjuryinducedbyischemiareperfusioninanimalmodels AT shuangyihuang theefficacyofmesenchymalstemcellsintherapyofacutekidneyinjuryinducedbyischemiareperfusioninanimalmodels AT tianbiaozhou efficacyofmesenchymalstemcellsintherapyofacutekidneyinjuryinducedbyischemiareperfusioninanimalmodels AT chunlingliao efficacyofmesenchymalstemcellsintherapyofacutekidneyinjuryinducedbyischemiareperfusioninanimalmodels AT shujunlin efficacyofmesenchymalstemcellsintherapyofacutekidneyinjuryinducedbyischemiareperfusioninanimalmodels AT wenshanlin efficacyofmesenchymalstemcellsintherapyofacutekidneyinjuryinducedbyischemiareperfusioninanimalmodels AT hongzhenzhong efficacyofmesenchymalstemcellsintherapyofacutekidneyinjuryinducedbyischemiareperfusioninanimalmodels AT shuangyihuang efficacyofmesenchymalstemcellsintherapyofacutekidneyinjuryinducedbyischemiareperfusioninanimalmodels |